Leishmania survives by exporting miR-146a from infected to resident cells to subjugate inflammation

Satarupa Ganguly1, Bartika Ghoshal1, Ishani Banerji1,2

  • 1RNA Biology Research Laboratory, Molecular Genetics Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India.

Life Science Alliance
|February 25, 2022
PubMed

Insights

Leishmania donovani manipulates host microRNAs (miRNAs) to control inflammation during visceral leishmaniasis. Infected cells export miR-146a to suppress inflammation and promote M2 macrophage polarization, aiding parasite survival.

Area of Science:

  • Parasitology
  • Immunology
  • Molecular Biology

Background:

  • Leishmania donovani causes visceral leishmaniasis by infecting macrophages.
  • The communication between infected and non-infected cells in regulating infection is not well understood.
  • Parasite survival strategies involve manipulating host cellular processes.

Purpose of the Study:

  • To elucidate the role of intercellular miRNA transport in Leishmania donovani infection.
  • To understand how infected cells regulate host inflammatory responses via miRNA exchange.
  • To investigate the mechanisms by which Leishmania donovani manipulates host miRNA profiles for its survival.

Main Methods:

  • Analysis of extracellular vesicle-mediated miRNA transfer between host cells.
  • Investigation of host cell mitochondrial function in response to infection.
  • Assessment of miRNA expression and function in infected and non-infected cells.
  • Macrophage polarization assays (M1/M2) and cytokine expression analysis.

Main Results:

  • Leishmania donovani prevents mitochondrial dysfunction to restrict miR-122 entry into infected macrophages, limiting inflammation.
  • The parasite up-regulates the export of miR-146a from infected cells via extracellular vesicles.
  • miR-146a restricts miR-122 production in hepatocytes and polarizes neighboring macrophages to the M2 state.
  • In recipient macrophages, miR-146a inhibits pro-inflammatory cytokine production and up-regulates IL-10 by promoting miR-21 export, inducing M2 polarization.

Conclusions:

  • Leishmania donovani employs a dual miRNA strategy to evade host immunity and promote survival.
  • Intercellular miRNA transport is a critical mechanism for parasite-induced immune modulation.
  • Targeting host miRNA pathways represents a potential therapeutic strategy for visceral leishmaniasis.

Related Concept Videos

Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...